# An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

> **NCT01599494** · PHASE3 · WITHDRAWN · sponsor: **Organon and Co**

## Conditions studied

- Infertility

## Interventions

- **DRUG:** MK-8962
- **DRUG:** recFSH
- **DRUG:** Ganirelix
- **DRUG:** human Chorionic Gonadotropin (hCG)
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT01599494
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599494, "An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01599494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*